Chronic Coronary Syndrome encompasses the broad spectrum of long-term coronary artery disease characterized by stable ischemia, progressive atherosclerosis, microvascular dysfunction, and fluctuating symptom burden. This session provides a comprehensive framework for diagnosing, evaluating, and managing stable angina, endothelial dysfunction, and long-term coronary risk. As demand grows for a structured cardiology conference, this session clarifies how chronic ischemic syndromes differ from acute events while requiring equally meticulous management.

Participants will explore the pathophysiology of plaque evolution, impaired vasomotor function, microvascular angina, and supply-demand mismatch. Case-based discussions demonstrate how to interpret stress testing modalities, coronary CT angiography, functional flow assessment (FFR/iFR), and biomarkers. The content also describes challenges associated with atypical symptoms, female-specific presentations, and comorbidities that alter symptom perception.

A major part of this session centers on implementing comprehensive chronic coronary management strategies. These include anti-anginal therapy, lipid optimization, blood pressure control, antiplatelet therapy, diabetes management, lifestyle modification, and cardiac rehabilitation. Participants will review updated guidelines, indications for revascularization, shared decision-making in stable disease, and tools for improving long-term adherence.

The session concludes with discussions on risk-based follow-up, digital monitoring, patient education, and preventing destabilization. By the end, clinicians will be equipped to deliver individualized chronic coronary care that reduces events and improves quality of life.